Allergan and the Dystonia Medical Research Foundation (DMRF) have announced continuation of their long-standing partnership in support of dystonia patients by conducting a survey to evaluate awareness of cervical dystonia, its symptoms and treatment options in order to encourage education and proper diagnosis of this often-disabling condition.

"Our partnership with Allergan on this survey will support patients with cervical dystonia and their families by shedding light on the lack of awareness of the condition," said Art Kessler, DMRF president. "It is imperative that patients have accurate information about cervical dystonia in order to seek the appropriate care and treatment options. Equally as critical, is continuing to work with a healthcare provider."

Dystonia is a chronic movement disorder that is estimated to affect as many as 250,000 people in the United States, making it the third most common movement disorder behind essential tremor and Parkinson's disease. It is identified by involuntary muscle contractions that cause repetitive movements and abnormal postures of the body and limbs. There are numerous subtypes that affect people of all ages and backgrounds, including cervical dystonia. Common symptoms of cervical dystonia include abnormal head position and neck pain. Allergan's Botox (onabotulinumtoxinA) is a first-line treatment to treat the abnormal head position and neck pain associated with cervical dystonia in people 16 years and older.

"Allergan is committed to supporting patients with cervical dystonia and educating the public about this condition in order to encourage proper diagnosis and treatment," said Mitchell Brin, M.D., senior vice president global drug development and chief scientific officer, Botox. "We value our continued partnership with the DMRF to raise awareness of cervical dystonia, potential treatment options and the importance of talking to your doctor."

DMRF's partnership with Allergan has also included raising awareness through Dystonia Zoo Walks in ten cities across the United States. These community events bring together patients, healthcare providers and families and increase visibility of dystonia. To date, 150,000 people have become more educated on dystonia through these events.

Botox is a prescription medicine that is injected into muscles and used to treat the abnormal head position and neck pain that happens with cervical dystonia (CD) in people 16 years and older.